Day: February 14, 2023

Hydro entered 2022 on the back of the strongest aluminium markets in decades following the aftermath of the Covid-19 pandemic. However, the year would soon be dominated by a devastating war in Europe, an energy crisis, spiking inflation and a global economic slowdown, including a significant fall in aluminium demand. We are pleased to present Hydro’s best financial result ever during what turned into a challenging year. The past year has once again shown us how fast things can change in our business environment, how important it is to be robust and resilient, and not to lose sight of the long-term opportunities. Our people are the foundation on which we are built Hydro’s most precious asset is our workforce of 32,000 highly skilled and engaged employees around the world. We see a direct link between the health, safety and wellbeing of...

22% year-on-year increase of royalty income from antifungal Cresemba® Operating profit of CHF 18.5 million and net profit of CHF 12.1 million Strengthened balance sheet through non-dilutive repayment of convertible bonds Expecting approximately 20% growth in Cresemba and Zevtera related revenue in 2023 and significant increase in net profit Well positioned for building an anti-infectives R&D portfolio to support sustainable long-term growthAd hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, February 14, 2023 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial or fungal infections, announced today its results for the financial year ended December 31, 2022. David Veitch, Chief Executive Officer, stated: “2022 was...

The Board of Directors of Norsk Hydro ASA have decided to propose to the General Meeting a dividend of NOK 5.65 per share on the basis of the company’s financial statements for the financial year 2022. Dividend amount: NOK 5.65 per share   Declared currency: NOK   Last day including right: 10 May 2023   Ex-date: 11 May 2023   Record date: 12 May 2023   Payment date: 23 May 2023   Date of approval: 10 May 2023   Investor contact: Line Haugetraa +47 41406376 Line.Haugetraa@hydro.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

February 14, 2023Hamilton, Bermuda Key information relating to the cash dividend to be paid by Flex LNG Ltd. (Ticker: FLNG) for the fourth quarter 2022 Note to shareholders registered in Euronext VPS, the Norwegian Central Security Depository:Due to implementation of the Central Securities Depository Regulation (CSDR) in Norway, please note the information on the payment date to the shares registered in Euronext VPS below. Dividend amount: $1.00Declared currency: USD. Dividends payable to shares registered with Euronext VPS will be distributed in NOK.Last day including right: 21 February 2023Ex-date: 22 February 2023Record date: 23 February 2023Payment date: On or about 7 March 2023. Due to the implementation of CSDR in Norway, dividends payable to shares registered with Euronext VPS will be distributed on or about 9 March 2023. Date of...

January 2023 began with good results for LHV Group – with revenues slightly ahead of the new financial plan and the quality of the credit portfolio maintained. LHV Group’s consolidated loan portfolio decreased by EUR 5 million over the month. Retail loans grew by EUR 3 million, although the volume of business loans decreased by nearly EUR 7 million. Consolidated deposits grew by EUR 57 million in January, while deposits belonging to financial intermediaries increased by EUR 16 million. The volume of funds managed by LHV increased by EUR 103 million over the month. In January, 2.9 million in payments related to financial intermediary clients were processed. In January, AS LHV Group earned EUR 10.7 million in consolidated net profit. AS LHV Pank earned EUR 12.3 million in net profit, of which EUR 2.1 million was from servicing clients related...

Global Bioenergies: First significant sales in 2022 Start of commercial production and sales of €0.7m Gross cash position of €8.8m at 31 December 2022 CSR maturity score of 56/100 on the Gaïa index, above the national average Paris, 14 February 2023: The Board of Directors of Global Bioenergies yesterday approved the annual financial statements for 2022, which show a controlled loss of €12m.1 Samuel Dubruque, Chief Financial Officer of Global Bioenergies, said: “2022 was marked by the construction and commissioning of the Pomacle unit and the organisation of the entire chain of tollers for the production of Isonaturane®. 2022 also saw revenue rise from €100,000 to €700,000, even without taking into account the delivery of the first batch of Isonaturane® – to L’Oréal, among other clients – scheduled for H1 2023. The net loss is similar...